The differences in the levels of tTG-IgA (p = 0.11), tTG-IgG (p = 0.17), AGA-IgA (p = 0.51) AGA-IgG (p = 0.23) between psoriasis patients who used MTX and the control group were not significant. The gene discussed is CD79A; the disease is psoriasis.